It is demonstrated that the interaction between tumor-associated macrophages and CAFs could facilitate cancer cells to gain gemcitabine and paclitaxel resistance in pancreatic and breast cancer in an IGF-1/2-dependent manner [54, 55]. Here, IGF1 is linked to cancer.